8 results  1 of 1 

1 Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer
Xuguang Zhu, Sheue-yann Cheng
Endocrinol Metab.2017;32(3):326-331.   Published online 2017 September 18     DOI: http://dx.doi.org/10.3803/EnM.2017.32.3.326
      
2 Effects of Histone Deacetylase Inhibitor (Valproic Acid) on the Expression of Hypoxia-inducible Factor-1 Alpha in Human Retinal Müller Cells
Young Jun Kim, Sang Jun Park, Na Rae Kim, Hee Seung Chin
Korean J Ophthalmol.2017;31(1):80-85.   Published online 2017 February 2     DOI: http://dx.doi.org/10.3341/kjo.2017.31.1.80
      
3 Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy
Erta Kalanxhi, Karianne Risberg, Imon S. Barua, Svein Dueland, Stein Waagene, Solveig Norheim Andersen, Solveig J. Pettersen, Jessica M. Lindvall, Kathrine Røe Redalen, Kjersti Flatmark, Anne Hansen Ree
Cancer Res Treat.2017;49(2):374-386.   Published online 2016 July 28     DOI: http://dx.doi.org/10.4143/crt.2016.080
      
4 HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
Somy Yoon, Gwang Hyeon Eom
Chonnam Med J.2016;52(1):1-11.   Published online 2016 January 19     DOI: http://dx.doi.org/10.4068/cmj.2016.52.1.1
      
5 A Novel Osteogenic Activity of Suberoylanilide Hydroxamic Acid is Synergized by BMP-2
Zang Hee Lee, Hyun-Jung Kim, Hyun Mo Ryoo
J Bone Metab.2015;22(2):51-56.   Published online 2015 May 31     DOI: http://dx.doi.org/10.11005/jbm.2015.22.2.51
      
6 Sequence-Dependent Radiosensitization of Histone Deacetylase Inhibitors Trichostatin A and SK-7041
Jin Ho Kim, Il Han Kim, Jin Hee Shin, Hak Jae Kim, In Ah Kim
Cancer Res Treat.2013;45(4):334-342.   Published online 2013 December 31     DOI: http://dx.doi.org/10.4143/crt.2013.45.4.334
      
7 Osteoblast differentiation of human bone marrow stromal cells (hBMSC) according to age for bone tissue engineering
Gin-Ah Song, Hyun-Mo Ryoo, Jin-Young Choi
J Korean Assoc Oral Maxillofac Surg.2010;36(4):243-249.   Published online 2010 January 10     DOI: http://dx.doi.org/10.5125/jkaoms.2010.36.4.243
   
8 New Promising Therapeutic Modalities for Thyroid Cancers: Histone Deacetylase Inhibitor, PPAR-gamma Agonist, and Retinoic Acid
Woung Youn Chung, Orlo H Clark
Korean J Endocr Surg.2005;5(2):69-74.   Published online 2005 December 31     DOI: http://dx.doi.org/10.16956/kjes.2005.5.2.69
      

 1 of 1